banner
May 2015
David Craig, PharmD | Editor

Education

Obtain Your Annual Meeting Continuing Education Credit

Evaluations for the 2015 Annual Scientific Meeting are now available. Certificates of continuing education credit will be issued upon completion of the online meeting evaluation form.

Access Evaluations


Poster Abstracts Are Live

The abstracts presented at the 34th Annual Scientific Meeting in Palm Springs are now available online through The Journal of Pain’s searchable abstract database.

To view abstracts, use the “search within this issue” link in the upper-right of the database to search only for abstracts that were presented in Palm Springs (rather than all archived issues of The Journal of Pain). The database allows you to search for topics of interest and view full abstracts for all accepted posters

 


 

Now Open: 2016 Call for Symposia

Are you interested in presenting your research to multidisciplinary pain researchers and clinicians? This is your chance to do so!

The 2016 APS Scientific Program Committee invites you to submit your proposals  for presentations. Submitted proposals must reflect APS’s multidisciplinary approach to pain and should include presenting the areas of pain science, translational research, and treatment. Shared Interest Groups (SIGs) are also invited to submit formal proposals for their 2016 SIG meetings for continuing education credit.

The 35th Annual Scientific Meeting will be held in Austin, May 11–14. The deadline for submissions is Monday, July 20. Learn more.

 


 

Pain Control for Primary Care Conference

July 23–25

Walt Disney World Swan Hotel, Orlando, Florida

Provided by the American Pain Society and Global Academy for Medical Education

APS and the Global Academy for Medical Education will present the second annual Pain Care for Primary Care (PCPC) course in July. The course is dedicated to helping primary care physicians, advanced practice nurses, and physician assistants improve care for patients experiencing pain and pain-related symptoms. Faculty will be composed of nationally known experts in the field, each chosen for their unique expertise in the field of pain care. Course topics will include

  • Regulations and Safe Practices in Prescribing Controlled Substances
  • Back Pain
  • Best Approach to Treat Migraines
  • Medical Marijuana, Clinical Practice Guidelines and Emerging Therapies
  • Osteoarthritis
  • Diabetic Peripheral Neuropathy
  • Aging Patients
  • Fibromyalgia
  • Non-Opioid Analgesics and Adjuvants
  • Patients with Addiction History
  • The Treatment Agreement.

This year, the PCPC course will also feature an optional 3-hour session on Risk Evaluation and Mitigation Strategies (Opioid REMS) for Extended-Release and Long-Acting Opioids.

For more information regarding the topics, faculty, agenda, and continuing education hours for the PCPC course, visit www.pcpc-cme.com.


APS Announces the Launch of the NEW CO*RE REMS Activity on Medscape

As a Collaborative for REMS Education (CO*RE) partner, APS is pleased to share the launch of a new CO*RE educational activity―REMS for ER/LA Opioid Analgesics: The Keys to Safe Use.

REMS for ER/LA Opioid Analgesics: The Keys to Safe Use (link requires login), launched in March, is an online activity that includes three modules provided in various formats, including text, multimedia, and video. The goal of this activity is to provide education on the safe use of extended-release (ER), long-acting (LA) opioid analgesics.

Additional resources include

  • FDA Blueprint for ER and LA opioid analgesics
  • CO*RE Completer Deck
  • patient counseling document
  • ER/LA opioid drug information.

Upon completion of this activity, participants will be able to

  • describe appropriate patient assessment for treatment with ER/LA opioid analgesics
  • evaluate the risks and potential benefits of ER/LA opioid analgesics
  • summarize the key components of safe use of ER/LA opioid analgesics
  • demonstrate accurate knowledge about how to initiate and manage therapy with ER/LA opioid analgesics, including appropriate monitoring for adverse effects and possible misuse.

This resource also provides the option to print, e-mail, and share via social media. A Medscape login is required to view this information.